EGF and neoplasm: Immunohistochemical studies in gastric and colorectal carcinoma have shown that CD97 and CD55 are localized to the tumor’s invasive front and correlate with both TNM stage and survival, further implicating EGF(1,2,5) expression as an important prognostic factor [32–35].